Runway Growth Finance Corp (NASDAQ: RWAY) is a specialty finance company that provides senior secured loans to high-growth-potential companies in technology, healthcare, business services, financial services, and select consumer services and products. Revenue comes primarily from interest income on these senior secured debt investments, structured with floating-rate spreads over SOFR or Prime, plus end-of-term payments (ETP) and, in some cases, payment-in-kind (PIK) interest components. The company also receives warrants and equity co-investments alongside its debt positions, giving it upside participation in borrower exits. RWAY is structured as an externally managed, non-diversified closed-end management investment company under the Investment Company Act of 1940, incorporated in Maryland and formed on August 31, 2015. Its target borrowers are venture capital-backed companies that cannot access conventional bank financing because traditional lenders underwrite to tangible asset values or operating cash flow, segments where RWAY faces limited direct competition due to high barriers to entry in venture lending.
Senior secured term loans, revolving credit facilities, second lien loans, bridge loans, and warrant or equity co-investments to venture capital-backed growth companies across technology, healthcare, business services, financial services, and select consumer sectors.
Interest income on senior secured floating-rate loans (SOFR-based or Prime-based spreads with floors), end-of-term payments, PIK interest, and gains from warrant and equity investments held alongside debt positions.
Venture capital-backed, high-growth-potential companies in application software, systems software, healthcare technology, pharmaceuticals and biotechnology, commercial and professional services, consumer services, consumer staples distribution, media and entertainment, property and casualty insurance, and technology hardware. Borrowers are typically unable to obtain financing from commercial banks due to limited tangible assets or negative operating cash flow.
Primarily United States-based portfolio companies, with select international borrowers including Marley Spoon SE and FINN GmbH, and Shield Therapeutics PLC, as disclosed in the FY2025 10-K filed 2026-03-12.
Loading...